PMN - ProMIS Neurosciences Inc.
24.05
-0.550 -2.287%
Share volume: 57,166
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$24.60
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-12-2025 | 08-13-2025 | 11-12-2025 | |
| Assets | ||||
| Total Assets | 13.647 M | 9.509 M | 21.458 M | |
| Current Assets | 13.647 M | 9.509 M | 21.458 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 33.051 K | 33.051 K | 33.051 K | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 8.364 M | 4.510 M | 15.399 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 13.647 M | 9.509 M | 21.458 M | |
| Total liabilities | 4.175 M | 9.892 M | 12.271 M | |
| Total current liabilities | 4.056 M | 9.824 M | 12.211 M | |
| Accounts Payable | 1.200 M | 2.780 M | 4.211 M | |
| Other liabilities | 5.592 K | 5.592 K | 5.592 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 5.592 K | 5.592 K | 5.592 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.472 M | -382.578 K | 9.187 M | |
| Common stock | 107.878 M | 108.141 M | 129.291 M | |
| Retained earnings | -98.035 M | -108.152 M | -119.732 M |